Found: 12
Select item for more details and to access through your institution.
Myofibroblasts enable invasion of endothelial cells into three-dimensional tumor cell clusters: a novel in vitro tumor model.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 52, n. 4, p. 263, doi. 10.1007/s00280-003-0664-2
- By:
- Publication type:
- Article
Targeting of a novel fusion protein containing methioninase to the urokinase receptor to inhibit breast cancer cell migration and proliferation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 52, n. 4, p. 270, doi. 10.1007/s00280-003-0666-0
- By:
- Publication type:
- Article
A phase I study of ZD0473 combined with paclitaxel for the treatment of solid malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 52, n. 4, p. 277, doi. 10.1007/s00280-003-0633-9
- By:
- Publication type:
- Article
Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 52, n. 4, p. 282, doi. 10.1007/s00280-003-0658-0
- By:
- Publication type:
- Article
Selective enhancement of ifosfamide-induced toxicity in Chinese hamster ovary cells.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Phase II study of docetaxel and topotecan combination chemotherapy in patients with advanced head and neck cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 52, n. 4, p. 303, doi. 10.1007/s00280-003-0673-1
- By:
- Publication type:
- Article
Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 52, n. 4, p. 307, doi. 10.1007/s00280-003-0668-y
- By:
- Publication type:
- Article
Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 52, n. 4, p. 319, doi. 10.1007/s00280-003-0641-9
- By:
- Publication type:
- Article
The role of DNA synthesis inhibition in the cytotoxicity of 2′,2′-difluoro-2′-deoxycytidine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 52, n. 4, p. 325, doi. 10.1007/s00280-003-0661-5
- By:
- Publication type:
- Article
A phase I study of 9-aminocamptothecin as a colloidal dispersion formulation given as a fortnightly 72-h infusion.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 52, n. 4, p. 333, doi. 10.1007/s00280-003-0657-1
- By:
- Publication type:
- Article
A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Equivalent single-dose pharmacokinetics of two different dosing methods of prolonged-release fulvestrant ('Faslodex') in postmenopausal women with advanced breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 52, n. 4, p. 346, doi. 10.1007/s00280-003-0643-7
- By:
- Publication type:
- Article